Maud Charpentier

Cornell University — United States

Medicine · Health Sciences

10h-index884citations37works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(15), Immunotherapy and Immune Responses(15), Immune Cell Function and Interaction(10), CAR-T cell therapy research(7), Immune cells in cancer(5)

Publications37 total

905 Regulation of radiation-induced innate immune signaling in patient-derived triple-negative breast cancer organoids
Regular and Young Investigator Award Abstracts·2025Open Access
Abstract B007: Tissue-Specific B Cell Differentiation Limits Anti-Tumor Efficacy of Radiation and Immunotherapy
Cancer Immunology Research·2025
Abstract PR-13: Myeloid checkpoint blockade potentiates radiotherapy by modulating dendritic cells and reducing Treg-driven immunosuppression
Cancer Immunology Research·2025
Abstract A023: Myeloid checkpoint blockade potentiates radiotherapy by modulating dendritic cells and reducing Treg-driven immunosuppression
Cancer Immunology Research·2025
Abstract 2194: Patient-derived triple negative breast cancer organoids show heterogeneous radiation-induced immune signaling
Cancer Research·2025· 1 cited
487 The SIRPα myeloid checkpoint regulates the functional differentiation of conventional dendritic cells type 3 (cDC3) in the tumor microenvironment
Regular and Young Investigator Award Abstracts·2024Open Access
Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids
Journal of Visualized Experiments·2024· 1 cited
860 CD40 agonism is required to promote the function of cross-presenting dendritic cells and increase triple negative breast cancer response to radiation and CTLA4 inhibition
Regular and Young Investigator Award Abstracts·2023Open Access
CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response
OncoImmunology·2023· 4 citedOpen Access
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
Nature Communications·2023· 58 citedOpen Access
Supplementary Figures from Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
2023Open Access
Data from Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
2023Open Access
Data from Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
2023Open Access
Supplementary Figures from Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses
2023Open Access
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors
Research Square (Research Square)·2022· 2 citedOpen Access
Radiation therapy-induced remodeling of the tumor immune microenvironment
Seminars in Cancer Biology·2022· 119 cited
264 SIRPa blockade synergizes with radiation therapy in murine breast cancer models
Regular and Young Investigator Award Abstracts·2021· 1 citedOpen Access
hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote MELOE‐1 translation in stressed melanoma cells
Molecular Oncology·2021· 20 citedOpen Access
Author response for "hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote its translation in stressed melanoma cells"
2021Open Access
Abstract LB168: Blocking SIRPα on myeloid cells synergizes with radiation therapy in mouse breast cancer models
Cancer Research·2021
page 1 of 2Next →

Frequent Co-authors

Sandra Demaria(23), Silvia C. Formenti(12), Claire Lhuillier(8), Karsten A. Pilones(7), Nathalie Labarrière(6), Alicia Alonso(6), Nils-Petter Rudqvist(5), Tuo Zhang(5), Sheila Spada(5), François Lang(5), Camille Daviaud(5), Jeffrey Kraynak(5), Joseph Aryankalayil(5), Doron Betel(5), Sergio Trombetta(5), Xi Kathy Zhou(4), Catherine Rabu(4), Agnès Fortun(4), Laëtitia Florenceau(3), Émilie Dupré(3)